BCTX Valuation
Briacell Therapeutics Corp
$
4.290
- Overview
- Forecast
- Valuation
BCTX Relative Valuation
BCTX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BCTX is overvalued; if below, it's undervalued.
Historical Valuation
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
3.51
P/B
Median3y
-7.56
Median5y
0.24
-139.62
FCF Yield
Median3y
-63.36
Median5y
-45.39
Competitors Valuation Multiple
The average P/S ratio for BCTX's competitors is 5.20, providing a benchmark for relative valuation. Briacell Therapeutics Corp Corp (BCTX) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch
SANA
Sana Biotechnology Inc
1.650
USD
+4.43%
MBWM
Mercantile Bank Corp
40.680
USD
+0.92%
HBT
HBT Financial Inc
21.990
USD
+0.07%
IBCP
Independent Bank Corp (Michigan)
30.120
USD
+0.80%
ALAR
Alarum Technologies Ltd
8.230
USD
+9.44%
CTKB
Cytek Biosciences Inc
3.650
USD
-0.54%
OSPN
OneSpan Inc
14.350
USD
-0.76%
FNKO
Funko Inc
4.370
USD
+8.71%
PUBM
PubMatic Inc
9.130
USD
+12.16%
CCAP
Crescent Capital BDC Inc
15.500
USD
+2.18%
FAQ
Is Briacell Therapeutics Corp (BCTX) currently overvalued or undervalued?
Briacell Therapeutics Corp (BCTX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Briacell Therapeutics Corp (BCTX) is between to according to relative valuation methord.
What is Briacell Therapeutics Corp (BCTX) fair value?
How does BCTX's valuation metrics compare to the industry average?
What is the current P/B ratio for Briacell Therapeutics Corp (BCTX) as of Apr 20 2025?
What is the current FCF Yield for Briacell Therapeutics Corp (BCTX) as of Apr 20 2025?
What is the current Forward P/E ratio for Briacell Therapeutics Corp (BCTX) as of Apr 20 2025?